ライフサイエンスコーパス: microdialysate

1 cose and lactate, respectively, in rat brain microdialysate.

2 gin of neurochemicals in cerebrospinal fluid microdialysate.

3 determine the glutamate concentration in the microdialysate.

4 panel of monoamines in rat prefrontal cortex microdialysates.

5 as not applicable to the high ionic strength microdialysates.

6 inistered directly into the striatum via the microdialysate (20 microM of METH for 10 min), or via pe

7 and males showed nearly a 4-fold increase in microdialysate 5-HT in response to fluoxetine while smal

8 terone, 48 h after estrogen priming, reduced microdialysate 5-HT near the threshold for detection.

9 pike analyses of offline-collected rat brain microdialysate and (ii) in vivo dynamic monitoring of th

10 n hypothalamic paraventricular nucleus (PVN) microdialysate and arterial plasma simultaneously during

11 etermine the degree of equilibration between microdialysate and interstitium for each probe to accura

12 ne and large neutral amino acids in striatal microdialysate, as well as in tissue from striatum and m

13 Proestrous females had the highest microdialysate concentrations of 5-HT during the light p

14 hepin, a 5-HT receptor antagonist, increased microdialysate concentrations of 5-HT.

15 Often, microdialysate concentrations of an analyte are only a f

16 At baseline, microdialysate contained low levels of IL-1alpha, IL-5,

17 is study, polygraphic recordings and caudate microdialysate dopamine measurements in narcoleptic dogs

18 nthesis and examined DOPA levels in striatal microdialysate during perfusion with NSD-1015.

19 Striatal microdialysates, each collected over a 20 min interval,

20 high-velocity impact traumatic brain injury, microdialysate extracellular fluid neurofilament heavy c

21 At rest, blood samples and microdialysates from adipose tissue and skeletal muscle

22 of ascorbic-acid and antioxidant capacity in microdialysates from cladodes of Opuntia ficus-indica (L

23 In striatal microdialysate, GBL markedly lowered DA levels; tyrosine

24 1 excretion, renal cortical ET-1 addition to microdialysate in vivo, and renal cortical ET-1 mRNA, co

25 nalytical chemical measurements of intra-SCN microdialysates in mouse, we found significant neurotran

26 g/kg i.p.) increased DOPA levels in striatal microdialysate, increased tissue DA levels in the MPFC a

27 By sequentially loading brain microdialysate into the dual sample collection loops, th

28 5-HT), and normetanephrine (NM) in rat brain microdialysates is to improve detection sensitivity.

29 Microdialysate lactate and pyruvate were unchanged, but

30 IL and IP microdialysate lactate, pyruvate, glucose and glycerol w

31 his method, 3-NT was detected in human liver microdialysate (levels up to 2.6 nM), although levels in

32 f intraperitoneal (IP) and intraluminal (IL) microdialysate metabolites in depicting ex vivo small in

33 Ex vivo time sequences of microdialysate metabolites were described and ROC analys

34 ytes at baseline and only slightly augmented microdialysate NE responses to IMMO.

35 induced prolonged elevations of hypothalamic microdialysate NE, as well as plasma ACTH and corticoste

36 s by 4.3, 7.3, 2.5, 0.6 and 1.8-fold and PVN microdialysate NE, DHPG, and DOPAC by 1.2, 0.6 and 0.5-f

37 also enhanced effects of IMMO on plasma and microdialysate NE, DHPG, and DOPAC.

38 table in suction blister fluid but in dermal microdialysate NO was present at 44.3 ng per ml (SEM 6.2

39 During ischemia, microdialysate norepinephrine concentrations increased i

40 ntrol and DSP-4-treated animals, hippocampal microdialysate norepinephrine concentrations were measur

41 -serine are simultaneously quantified in the microdialysate of an arctic ground squirrel to illustrat

42 Analysis of in vitro microdialysates of hemolymph revealed more neuropeptides

43 a the PVN microdialysis probe did not affect microdialysate or plasma levels of the analytes at basel

44 In Group A, lactate levels in the donor microdialysate rose to >6 mM (P < 0.05), were significan

45 mine concentrations in rat prefrontal cortex microdialysate samples followed by administration of SKF

46 This method was used to analyze in vivo microdialysate samples from probes implanted in the stri

47 We first measured glutamate in 2 min microdialysate samples from the MPOA before, during, and

48 for determination of dopamine in 1-min brain microdialysate samples is described.

49 was identified in electropherograms of brain microdialysate samples obtained from anesthetized rats.

50 ted using the internal reference method from microdialysate samples that were obtained from two micro

51 Microdialysate samples were collected every 15 min.

52 In an additional series of 13 rats, microdialysate samples were obtained before, during, and

53 Dopamine was readily detected in 1-min brain microdialysate samples.

54 al cortex were measured in 20-min samples of microdialysate taken during a 2-hr baseline, 40 min of s

55 M for lactate, based on a 20-muL conditioned microdialysate; these characteristics were sufficient to

56 l tissue tyrosine levels, but did not affect microdialysate tyrosine levels.

57 of biogenic monoamines in rat brain striatum microdialysates using capillary high-performance liquid

58 Basal NO concentration in dermal microdialysate was 0.60 +/- 0.14 microM (mean +/- s.e.m.

59 3 h intervals, and the endorphin content of microdialysates was analyzed by a solid-phase radioimmun

60 concentrations in the blood and hippocampal microdialysate were determined by LC/MS-MS; NO productio

61 s in LNAA levels in brain tissue and in vivo microdialysate were generally comparable.

62 with PEGDE-based biosensors, and when brain microdialysates were analyzed, the levels of glutamate d

63 d peak concentrations of melatonin in AH-POA microdialysates within 20 min of injection (165 +/- 34 a